Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 1,195.00
+3.00 (0.25%)
Mar 27, 2026, 3:30 PM JST
Kohjin Bio Market Cap
Kohjin Bio has a market cap or net worth of 6.11 billion as of March 27, 2026. Its market cap has decreased by -29.99% in one year.
Market Cap
6.11B
Enterprise Value
5.75B
Revenue
5.07B
Ranking
n/a
PE Ratio
10.97
Stock Price
1,195.00
Market Cap Chart
Since April 25, 2024, Kohjin Bio's market cap has decreased from 11.89B to 6.11B, a decrease of -48.61%. That is a compound annual growth rate of -29.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 6.11B | -19.74% |
| Dec 30, 2025 | 7.61B | -11.16% |
| Dec 30, 2024 | 8.57B | -27.92% |
| Apr 25, 2024 | 11.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 7.73B |
| CellSource | 7.70B |
| Carna Biosciences | 7.69B |
| Chiome Bioscience | 7.29B |
| PRISM BioLab Co.,LTD | 7.09B |
| Noile-Immune Biotech | 6.54B |
| TMS Co., Ltd. | 6.37B |
| Soiken Holdings | 6.30B |